PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics Post published:December 21, 2020 Post category:Press Release
Revive Therapeutics Announces LOI to Acquire PharmaTher’s Psilocybin Program Post published:December 21, 2020 Post category:Press Release
BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC Post published:December 21, 2020 Post category:Press Release
Beckley Psytech Raises £14m ($18.6m) to Advance Development of 5-MeO-DMT for Neuropsychiatric Diseases Post published:December 19, 2020 Post category:News
Entheon Biomedical Announces Private Placement Post published:December 18, 2020 Post category:Press Release
Psychedelic Bulletin: MindMed Raises $34.5m; Tryp Goes Public; What Health Canada’s Latest Amendment Means for Psychedelics Post published:December 18, 2020 Post category:Psychedelic Bulletin
Tryp Therapeutics Begins Trading on the Canadian Securities Exchange Post published:December 18, 2020 Post category:Press Release
Ehave, Inc. Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021 Post published:December 17, 2020 Post category:Press Release
MagicMed Industries Announces Closing of Upsized and Oversubscribed $8.1 Million Private Placement of Units Led by Gravitas Securities Due to Significant Investor Demand Post published:December 17, 2020 Post category:Press Release
Tryp Therapeutics Completes Initial Public Offering Post published:December 17, 2020 Post category:Press Release